# Trade Mark Journal No.2026/014 3 April 2026

## UK00004357011 18 March 2026 (5,42)

MIGHTY THERAPEUTICS

Class 5
  Biopharmaceutical preparations for the prevention and treatment of mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic diseases and disorders; biological preparations for the prevention and treatment of cellular abnormalities.
Class 42
  Scientific research and development; biopharmaceutical research, development and testing; medical and scientific research in the mitochondrial, cardiovascular, renal, ophthalmic, neurologic, myopathic and metabolic system fields.

Stealth BioTherapeutics Inc.

Representative: J A Kemp LLP